Vol 9, No 4 (2008)

Table of Contents

Editorial

Growing impact of pharmacogenomic on drug development and personalized medicine
Mario Eandi
PDF
171-172

Original research

Peg-interferon plus ribavirin in chronic hepatitis C: cost-efficacy and pharmacoutilization in clinical practice
Luisa Cavalletto, Elisabetta Bernardinello, Giulio Diodati, Enzo Raise, Angelo Gatta, Liliana Chemello
PDF
173-181

Review (Economic Analysis)

Epidemiology and costs of HPV infection: review of the evidence
Francesco Bamfi, Alessia Marocco, Stefano Capri, Mario Giovanni Sideri
PDF
183-189

Methods

Usefulness and limitation of DDD and PDD analyses. 12 months of solid oral antipsychotics prescribing data for the NHS-reimbursed treatment of schizophrenia in Italy
Lorenzo Pradelli
PDF
191-196

Brief drug profile

Telbivudine (Sebivo) in patients with hepatitis B virus (HBV) chronic infection
Viola Sacchi
PDF
215-218
Maraviroc (Celsentri) in HIV treatment
Viola Sacchi
PDF
219-222